@article{JTD26594,
author = {Sook-Hee Hong},
title = {Hippo pathway as another oncogenic mediator to promote immune evasion by PD-L1 signaling},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {The programmed cell death protein (PD)-1 and programed death ligand 1 (PD-L1) based immunotherapeutic agent is a cornerstone for the treatment of cancer. The expression of PD-L1 was developed as a biomarker to predict the efficacy of anti-PD1/PD-L1 pathway based immune check point inhibitor. In addition, increased PD-L1 in tumor and tumor microenvironment could be considered as representative biomarkers for immune suppressive microenvironment.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/26594}
}